Nebula Research & Development LLC Mimedx Group, Inc. Transaction History
Nebula Research & Development LLC
- $836 Billion
- Q3 2024
A detailed history of Nebula Research & Development LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 22,587 shares of MDXG stock, worth $214,124. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,587
Previous 38,471
41.29%
Holding current value
$214,124
Previous $267 Million
49.93%
% of portfolio
0.02%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding MDXG
# of Institutions
208Shares Held
98.1MCall Options Held
8KPut Options Held
65.3K-
Essex Woodlands Management, Inc. The Woodlands, TX28.2MShares$267 Million47.81% of portfolio
-
Black Rock Inc. New York, NY9.31MShares$88.3 Million0.0% of portfolio
-
Trigran Investments, Inc.7.69MShares$72.9 Million4.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.97MShares$66.1 Million0.0% of portfolio
-
Paradigm Capital Management Inc4.66MShares$44.2 Million1.25% of portfolio
About MIMEDX GROUP, INC.
- Ticker MDXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 113,609,000
- Market Cap $1.08B
- Description
- MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...